Lucio Tentori - Concepedia

Author

Lucio Tentori

University of Rome Tor Vergata ORCID

Also Known As

G VIVALDI, L TENTORI, L Tentori, L. TENTORI, L. Tentori, LUCIO TENTORI, Lucio Tentori

155

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Istituto Dermopatico dell'Immacolata Istituti di Ricovero e Cura a Carattere Scientifico Università Cattolica del Sacro Cuore Sapienza University of Rome

About

Lucio Tentori is an author at University of Rome Tor Vergata specializing in medicine, cell biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	38	1.5K
2	Allergy	3	3	99
3	Health Sciences	2	2	79
4	Natural Sciences	2	2	162
5	Biochemistry	1	1	39

Lucio Tentori

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis Stefania D’Atri, Lucio Tentori, Pedro Miguel Lacal, Molecular Pharmacology	1998	277
Systemic administration of GPI 15427, a novel poly(ADP-ribose) polymerase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. Lucio Tentori, Carlo Leonetti, Marco Scarsella, PubMed	2003	204
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis Lucio Tentori, Pedro Miguel Lacal, Alessia Muzi, European Journal of Cancer AngiogenesisNatural SciencesPathologyVascular BiologyNeovascularization	2007	146
PARP1 is activated at telomeres upon G4 stabilization: possible target for telomere-based therapy Erica Salvati, Marco Scarsella, Manuela Porru, Oncogene Signal TransductionTelomere-based TherapyMolecular BiologyG4 StabilizationPossible Target	2010	122
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide Lucio Tentori, Lucia Ricci‐Vitiani, Alessia Muzi, BMC Cancer	2014	105
Inhibition of poly(ADP‐ribose) polymerase prevents irinotecan‐induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma Lucio Tentori, Carlo Leonetti, Marco Scarsella, The FASEB Journal Parp InhibitorGastrointestinal PharmacologyGastroenterologyPathologyPharmacotherapy	2006	103
Ellagic Acid Inhibits Bladder Cancer Invasiveness and In Vivo Tumor Growth Claudia Ceci, Lucio Tentori, Maria Grazia Atzori, Nutrients Vivo Tumor GrowthUrologyOncologyChemoprevention StrategyGenitourinary Cancer	2016	99
Essential role of the interleukin 2-interleukin 2 receptor pathway in thymocyte maturation in vivo. Lucio Tentori, Dan L. Longo, Juan Carlos Zúñiga‐Pflücker, The Journal of Experimental Medicine Interleukin 2-Interleukin 2Lymphocyte DevelopmentImmune RegulationImmunologyImmune System	1988	93
Combined treatment with temozolomide and poly(ADP-ribose) polymerase inhibitor enhances survival of mice bearing hematologic malignancy at the central nervous system site Lucio Tentori, Carlo Leonetti, Marco Scarsella, Blood	2002	82
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells Maria Grazia Atzori, Lucio Tentori, Federica Ruffini, Journal of Experimental & Clinical Cancer Research	2017	70

Page 1